Oxygen firebreak

An oxygen firebreak, also known as a fire stop valve or fire safety valve, is a thermal fuse designed to extinguish a fire in the delivery tube being used by a patient on oxygen therapy and stop the flow of oxygen if the tube is accidentally ignited. Oxygen firebreaks are fitted into the oxygen delivery tubing close to the patient, typically around the patient's sternum where the two nasal cannula tubes join and connect to the delivery tubing.
Home oxygen fires.
Oxygen is not flammable, but when it is present in increased concentrations it will enable fires to start much more easily. Once a fire has started, if supplemental oxygen is present it will burn more fiercely, based on the principle of the fire triangle. Materials that do not burn in ambient air may burn when there is a greater concentration of oxygen present than there is in air.
Most home oxygen fires are caused by patients smoking whilst using medical oxygen. Despite the inherent dangers, researchers estimate that between 10 and 50 per cent of home oxygen patients continue to smoke. Other sources of naked flames, such as gas flames and birthday candles, can also pose a risk.
Once a fire has started in the patient's nasal cannula it will track back towards the oxygen source and if not stopped may lead to a ‘whole house’ fire. Whole house fires are directly correlated with single or even multiple deaths. According to the US National Fire Protection Association (NFPA), 25% of oxygen fires get beyond the immediate surrounding area to become ‘whole house’ fires.
While an oxygen firebreak / thermal fuse cannot stop the initial ignition, it can limit the potential for whole house fires, more serious injury and death. Firebreaks / thermal fuses can also buy more time for a patient and other individuals in the building to escape, and limit the material cost of fire damage.
Oxygen fire statistics.
A study, The prevalence and impact of home oxygen fires in the USA, published in September 2019, analysed media reports of home oxygen fire incidents between December 2017 and August 2019. The report found 311 incidents, resulting in 164 deaths, equivalent to one patient death every four days. It also found that a third of reported incidents referenced exploding cylinders, posing a significant risk to third parties, including emergency services. The estimates that there are between 100 and 150 deaths every year from home oxygen fires in the US, describing it as a ‘material health issue’.
In 2008 the NFPA published a report suggesting that there are 46 deaths each year in the US from 182 fires. The report also stated that US hospital emergency rooms deal with an average 1,190 cases of burns each year as a result of home oxygen fires. However, the NFPA describes these statistics as "likely underestimates".
Further analysis by Marty Ahrens on behalf of the NFPA in 2017 recorded a likely average annual death rate for home fires involving oxygen administration equipment of 70 people (or 3% or all home fire deaths), based upon figures between 2011 and 2015. The report also suggested that these fires or burns are becoming more common. In 2019 the NFPA also reported that "medicinal oxygen was involved in 13% of the home smoking material fire deaths".
The United States Fire Administration (USFA) said in a 2015 report that "While no one factor is solely responsible for the increased fire risk to older adults receiving home health care, smoking in the presence of oxygen is recognized as one important problem."
A study of home oxygen therapy patients in the Veterans Health Administration between 2009 and 2015 examined 123 cases of reported adverse events related to flash burns. It found that 100 cases (81%) resulted in injury, and 23 (19%) resulted in death. Although 89% of veterans claimed to have quit smoking, 92% of burns occurred as a result of smoking.
Not all European countries monitor data on the number of fires that occur as a result of home oxygen. Despite a European Union Medical Device Directive requiring incidents to be reported to national vigilance authorities, there is often inadequate coordination to publish the information centrally. According to the German Federal Institute for Drugs and Medical Devices (Bundesinstitut fur Arzneimittel und Medizinprodukte, BfArM) it is likely that such incidents are grossly under-reported.
In England and Wales, central reporting of adverse incidents is a requirement of the NHS Service Specification for Home Oxygen. After firebreaks became mandatory in 2006, the average number of deaths by fire was 0.36 per thousand patients per year. In the US, where firebreaks were not required, almost twice as many patients (0.62 patients per thousand) died. A Freedom of Information request in 2018 revealed that only fatality relating to home oxygen fires was recorded in the five-year period between 2013 and 2017.
Firebreak effectiveness.
In 2018, a freedom of information request to all clinical commissioning groups in England (where firebreaks are mandatory) revealed that during the five years between 2013 and 2017 inclusive, 63 serious incidents involving oxygen fires were recorded and just one fatality. 73% of CCGs, representing 71% of patients in England, responded to the request. When the results are extrapolated to cover the whole patient population of 81,000, the figures are 89 incidents and 1.4 deaths. The fatality rate is significantly lower than any other previous study in the UK or internationally, and significantly lower than rates in the US or Japan where, compared with the equivalent patient population, they were 27 and 14 respectively. The white paper report suggests that the mandatory introduction of firebreaks, in conjunction with a "multidisciplinary approach to patient education", as well as risk assessments, is responsible for the low level of fatalities.
Home oxygen fire incidents.
Some of the incidents involving deaths and injuries to patients, their relatives, fellow residents, as well as firefighters include:
Collelongo (L'Aquila), Italy. April 15, 2021
Bradford County, Pennsylvania, US. March 23, 2021
Vancouver, Washington, US. March 9, 2021
Nottingham, Maryland, US. December 3, 2020
Wellington, Kansas, US. September 22, 2020
Giromagny, France. March 8, 2020
Saint-Nazaire, France. January 12, 2020
Richmond, Indiana, US. November 19, 2018 
Tilford, South Dakota, US. September 7, 2018 
Fayetteville, Arkansas, US. July 14, 2018 
Marion County, Indianapolis, US. May 19, 2018
San Remo, Italy. March 23, 2017
Pont-Sainte-Maxence, Oise, France. March 11, 2017
Pau, France. February 19, 2017
Winchester, Kentucky, US. March 11, 2016
Knox County, Tennessee, US. February, 2012
Regulation.
United States.
Before placing a new concentrator on the market, all oxygen concentrator manufacturers need to make a 510(k) premarket submission to the US Food and Drug Administration (FDA).
If the manufacturer chose to apply ISO 80601-2-69:2014 to demonstrate the safety of the new device, the fire safety elements of the standard, including ‘a means to extinguish a tubing fire and isolate the oxygen flow’ are a requirement. Approval to market the product would then be based upon compliance to the standard.
In March, 2018, the US Veterans Health Administration issued a Patient Safety Alert mandating the use of thermal fuses in all its patients' home oxygen installations, unless there is a clinical reason for not doing so. The Patient Safety Alert applies to all patients, not just those deemed to be at 'high risk'. It requires two thermal fuses to be fitted per patient installation, and any unidirectional thermal fuses must be replaced with bidirectional versions at the next scheduled visit (unless the unidirectional thermal fuse is designed so it cannot be fitted in the wrong direction).
In January 2020, in coordination with Fire Departments around the state and other agencies, the Wyoming State Fire Marshals Office launched the statewide community risk 307 CRR initiative. This aims to “to reach users of home medical oxygen, place safety devices on their units, and provide a home-risk checkup for the residents when possible”. The initiative follows Wyoming fire data which revealed that more than fifty percent of the deaths in residential structure fires throughout the state have been in homes with medical oxygen. The goal of the initiative is to reduce fire deaths and injuries by 2024 by installing inline oxygen firebreaks in 100% of home using medical oxygen across the State.
Europe.
In the European Union the fitting of firebreaks is a legal requirement for all home oxygen installations.
All economic operators in the EU, including home oxygen service providers, must comply with the Medical Device Directive (93/42/EEC) or the Medical Device Regulation (2017/745).
The instructions for use for an oxygen concentrator placed on the EU single market must include an instruction to the effect that a firebreak shall be fitted close to the patient to stop the flow of oxygen in the event of a fire. By including this statement the oxygen concentrator manufacturer is complying with the harmonised EN ISO type standard for oxygen concentrators EN ISO 8359:2009+A1:2012, which provides the manufacturer with an immediate presumption of conformity to the Essential Requirements of the Medical Devices Directive and allows them to properly apply the CE mark. Since January 2015 all instructions for use provided with oxygen concentrators placed on the European market will include this statement.
The applied CE mark is reliant on the home oxygen service provider following this instruction and fitting a firebreak. If the firebreak is not fitted, then the Essential Requirements for performance and safety are not met and the CE mark is no longer valid. It also means that the home oxygen service provider's status, within the framework under which the single market for medical devices operates, changes from ‘distributor’ to ‘manufacturer’. This has significant regulatory implications.
The EU Medical Devices Directive also requires that economic operators adopt solutions that ‘reduce risk as far as possible’ in line with the ‘state of the art’. The fitting of firebreaks is therefore a requirement irrespective of the oxygen source, including oxygen concentrators, liquid oxygen dewars or gas cylinders.
United Kingdom.
An additional legal requirement applies in the UK, where the fitting of firebreaks has been mandatory under the service specification of the home oxygen service since 2006.
Germany.
In 2011, the German Federal Institute for Drugs and Medical Devices recommended ‘corrective actions to prevent fires in oxygen concentrators’. It issued a notice stating that from July 1, 2012 all devices should be equipped with installations for stopping encroachment of the fire into the device, and interruption of the delivery of oxygen in the accessory as close to the patient as possible, in case of ignition. Manufacturers were also required to offer retrospective refitting for devices placed on the market before July 1, 2012.
World Health Organization guidance.
The World Health Organization recommends ‘firebreak connectors to stop the oxygen flow in the event of fire’ in all oxygen concentrators.
Oxygen firebreak standards.
Three main standards cover the use of oxygen firebreaks / thermal fuses:
The safety requirements for oxygen concentrators are governed by the amended standard ISO 8359:1996+A1:2012. The US FDA recognized the standard from January 2014. In January 2015, it was superseded by ISO 80601-2-69:2014. Health Canada, which is responsible for national public health, still recognizes the standard.
All of the 28 CEN (European Committee for Standardization) national standardization bodies (NSBs) have published EN ISO 8359:2009+A1:2012 as national standards. In Europe EN ISO 8359:2009+A1:2012 has harmonized standard status, which triggers ‘presumption of conformity’.
Included in ISO 80601-2-69:2014 are specific requirements that serve to mitigate the risk of fire related to oxygen therapy. The requirements state that the following should be provided: